Table 5.
Multivariable logistic model to assess the effect of breast nurse intervention on adherence of endocrine therapy (tamoxifen) during a 12-month refill period.
| Variables | Self-reported Adherence status at 12 months | AOR (95% CI) | P-value | |
|---|---|---|---|---|
| Adhered frequency (%) | Not-adhered frequency (%) | |||
| Intervention status | ||||
| Intervention group | 28 (68.3) | 12 (42.9) | 4.05(1.17, 14.03) | .028a |
| Control group | 13 (31.7) | 16 (57.1) | 1 | |
| Stage at diagnosis | ||||
| I | 4 (9.8) | 5 (17.9) | 1 | |
| II | 19 (46.3) | 9 (32.1) | 1.93 (0.34, 10.94) | .47 |
| III | 16 (39.0) | 13 (46.4) | 0.94 (0.17, 5. 18) | .94 |
| IV | 2 (4.9) | 1 (3.6) | 2.51 (0.14, 45.2) | .53 |
| FNAC conducted | ||||
| Yes | 32 (78.0) | 20 (71.4) | 1.55 (0.38, 6.29) | .54 |
| No | 9 (22.0) | 8 (28.6) | 1 | |
| History of using ET | ||||
| Yes | 5 (12.2) | 6 (21.4) | 0.37 (0.84, 1.65) | .19 |
| No | 36 (87.8) | 22 (78.6) | 1 | |
| Advised to go to another place | ||||
| Yes | 26 (63.4) | 16 (57.1) | 1 | .46 |
| No | 15 (36.6) | 12 (42.9) | 0.62 (0.17, 2.25) | |
| Breast cancer can be detected early | ||||
| Yes | 20 (48.8) | 12 (42.9) | 1.73 (0.41, 7.23) | .45 |
| No | 13 (31.7) | 6 (21.4) | 2.59 (0.53, 12.73) | .24 |
| Do not know | 8 (19.5) | 10 (35.7) | 1 | |
ET, endocrine therapy; AOR, adjusted odds ratio.